Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Ava Science, Inc. (Ava Ovulation Bracelet)
Creekside Natural Therapies, LLC (Creekside Focused Mind, Jr. dietary supplement)
Retina-X Studios, LLC, In the Matter of
Retina-X Studios, LLC, reached a settlement with the Federal Trade Commission over allegations that the company and its owner failed to secure the data collected by its “stalking” apps and ensure the apps were used for legitimate purposes.
Statement of Commissioner Christine S. Wilson on the Energy Labeling Rule
T&M Protection Resources, LLC, In the Matter of
T&M Protection Resources, LLC, settled Federal Trade Commission allegations that the company misrepresented its participation in and compliance with the EU-U.S. Privacy Shield framework.
Telestar Consulting, Inc.
The Federal Trade Commission is sending refunds totaling more than $6.9 million to small businesses, non-profits, and government agencies targeted by an office supply telemarketing scam that charged them for products they did not order. The FTC alleged that defendants’ victims included child care centers, schools, and police and fire departments.
Health Center, Inc.
In March 2020, Nevada-based Health Center, Inc. (HCI) and its owner Peggy Pearce agreed to halt their allegedly deceptive advertising claims about three “cure-all” health and wellness products that targeted older consumers nationwide, in a settlement with the Federal Trade Commission. The order settling the FTC’s complaint prohibits HCI and Pearce from such deceptive conduct and imposes a partially suspended monetary judgment.
Vital Living Products, Inc. d/b/a American Water Service; and Donald R. Podrebarac
The marketers of a home test kit for anthrax, and an on-line seller of a colloidal silver product purported to treat anthrax, have both settled Federal Trade Commission charges of false and unsubstantiated product advertising.
Thomas Jefferson University, et al.
The Federal Trade Commission has issued an administrative complaint and authorized a federal court action to block the proposed merger of Jefferson Health and Albert Einstein Healthcare Network, two leading providers of inpatient general acute care hospital services and inpatient acute rehabilitation services in both Philadelphia County and Montgomery County, Pennsylvania. The proposed merger would eliminate the robust competition between Jefferson and Einstein for inclusion in health insurance companies’ hospital networks to the detriment of patients. The Commission vote to issue the administrative complaint and to authorize staff to seek a temporary restraining order and preliminary injunction was 4-0-1, with Chairman Joseph J. Simons recused. The administrative trial is scheduled to begin on Sept. 1, 2020.